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We read with interest the work by Haug et al. published in Gut.1  Longitudinal data from 
4,523 participants in the first round of a faecal immunochemical test for haemoglobin 
(FIT) based screening programme, of whom 3,427 also participated in the second 
round, were studied.  In both first and second rounds, a threshold of 10 µg Hb/g faeces 
was used.  The cohort was followed up for two years. The cumulative positivity and the 
number of participants diagnosed with neoplasia over the two rounds of screening were 
determined and compared with a hypothetical strategy involving single round screening 
with use of lower faecal haemoglobin concentration (f-Hb) thresholds and omission of 
the second round.  It was suggested that lowering the f-Hb threshold and extending the 
screening interval could possibly enhance population-based screening programmes.  
 
In our pilot evaluation of FIT-based screening in Scotland, a much higher f-Hb threshold 
(≥ 80 µg Hb/g faeces) was employed.2 Moreover, a much larger cohort of screened 
individuals (30,893) was available for study. 753 participants with f-Hb ≥ 80 μg Hb/g 
were referred for colonoscopy.  Of 30,140 with a negative screening test result, 27,890 
that had participated were eligible to be invited for the next screening round (January 
2011 to January 2013). Of 24,669 responders, 450 had a positive screening test result 
and were referred for colonoscopy.   In the two rounds of screening studied, the first 
with quantitative FIT using a threshold of ≥ 80 µg Hb/g faeces and the second using the 
standard gFOBT/FIT two-tier reflex algorithm used in Scotland,3 the positivity in the first 
round was 2.5%: there were 30 screen-detected cancers (SDC) and 31 interval cancers 
(IC).4 In the first round, 753 colonoscopies were performed. At the second round, there 
were 25 SDC, making a total of 55 SDC over two rounds.   
 Assuming that IC and CRC detected at the subsequent screening round would have 
been present in some form during the initial screening round, the scenarios that would 
have eventuated by omitting the second screening round and using lower f-Hb 
thresholds are listed in Table 1.  The f-Hb threshold that would have given double the 
positivity rate of that found using ≥ 80 µg Hb/g faeces was identified as ≥ 28 µg Hb/g 
faeces.  
 
This f-Hb threshold would have generated the same number of colonoscopies in a 
single four year screening round as a threshold of ≥ 80 µg Hb/g faeces would have in 
two rounds of biennial screening.  In this situation, which is colonoscopy resource 
neutral, three IC and nine second round CRC would have been detected during the first 
round of screening.  It follows that the remaining 16 SDC found in the second round 
would have become IC, or at least have been more advanced when detected at the next 
screening episode.  This would have resulted in 42 SDC diagnosed in a four year 
screening round, considerably fewer than the total of 55 SDC with biennial screening, 
and the number of IC could have potentially increased from 31 to 44.   
 
Therefore, the concept of lowering f-Hb cut-off and lengthening screening interval to 
improve test sensitivity without an increase in colonoscopy requirement is not supported 
by our data since a modest decrease in IC would be offset by the majority of second 
round SDC being missed. Other strategies such as the use of f-Hb concentration to 
determine the length of the subsequent screening interval for individual participants may 
be a better option when evolving to more intelligent use of FIT. 
 
Table 1. Alternative scenarios using lower faecal haemoglobin concentration (f-
Hb) threshold for the 1st round and omitting 2nd round 
f-Hb cut-off (≥ µg Hb/g 
faeces) 
Positivity 
in 1st 
round 
Screen-
detected 
cancer in 
1st round 
Interval 
cancers 
now 
detected 
 2nd 
round  
cancer 
now 
detected 
in 1st 
round 
Colonoscopies 
required in 1st 
round* 
60 3.1% 36 2/31 4/25 946 
40 3.9% 38 3/31 5/25 1194 
30 4.7% 41 3/31 8/25 1422 
28 5.0% 42 3/31 9/25 1500 
20 6.3% 47 5/31 12/25 1935 
15 7.4% 52 8/31 14/25 2288 
10 9.4% 54 8/31 16/25 2900 
 
*Numbers of colonoscopies derived from positivity  
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